On the public citation graph
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
0 signed · 6193 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/14651858.cd001964.pub3openalex-snapshot
Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach
inferredcites →https://doi.org/10.1002/14651858.cd004064.pub4openalex-snapshot
Chemotherapy for advanced gastric cancer
inferredcites →https://doi.org/10.1002/bjs.1800800829openalex-snapshot
Prognostic relevance of systematic lymph node dissection in gastric carcinoma
inferredcites →https://doi.org/10.1002/bjs.1800820954openalex-snapshot
Prognostic relevance of systemic lymph node dissection in gastric carcinoma
inferredcites →https://doi.org/10.1007/bf02307081openalex-snapshot
Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group study
inferredcites →https://doi.org/10.1016/j.ejso.2004.04.013openalex-snapshot
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
inferredcites →https://doi.org/10.1016/s0140-6736(02)08651-8openalex-snapshot
Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(02)49512-8openalex-snapshot
ROYAL SURREY COUNTY HOSPITAL.
inferredcites →https://doi.org/10.1016/s0140-6736(89)91607-3openalex-snapshot
ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER
inferredcites →https://doi.org/10.1016/s0959-8049(99)00076-3openalex-snapshot
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials
inferredcites →https://doi.org/10.1023/a:1008377101672openalex-snapshot
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials
inferredcites →https://doi.org/10.1038/bjc.1989.350openalex-snapshot
A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report
inferredcites →https://doi.org/10.1038/sj.bjc.6602572openalex-snapshot
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
inferredcites →https://doi.org/10.1038/sj.bjc.6690243openalex-snapshot
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial
inferredcites →https://doi.org/10.1038/sj.bjc.6690350openalex-snapshot
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
inferredcites →https://doi.org/10.1056/nejm199903253401202openalex-snapshot
Extended Lymph-Node Dissection for Gastric Cancer
inferredcites →https://doi.org/10.1056/nejmoa010187openalex-snapshot
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
inferredcites →https://doi.org/10.1093/oxfordjournals.annonc.a058932openalex-snapshot
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
inferredcites →https://doi.org/10.1136/bmj.307.6904.591openalex-snapshot
Gastric cancer: a curable disease in Britain.
inferredcites →https://doi.org/10.1200/jco.1993.11.8.1441openalex-snapshot
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
inferredcites →https://doi.org/10.1200/jco.1997.15.1.261openalex-snapshot
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
inferredcites →https://doi.org/10.1200/jco.2002.08.105openalex-snapshot
Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer
inferredcites →https://doi.org/10.1200/jco.2004.08.026openalex-snapshot
Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial
inferredcites →https://doi.org/10.1200/jco.2005.23.16_suppl.4001openalex-snapshot
Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3801770openalex-extracted
Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma
inferred← citeshttps://doi.org/10.2139/ssrn.3901763openalex-extracted
Is Prophylactic Hyperthermic Intraperitoneal Chemotherapy Beneficial to the Long-Term Survival of Patients After Radical Gastric Cancer Surgery: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.2139/ssrn.4016468openalex-extracted
A Novel Technique of 4K Laparoscopic Suprapancreatic Lymph Node Dissection After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer With Right Lateral Approach
inferred← citeshttps://doi.org/10.2139/ssrn.4113133openalex-extracted
Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multi-Center Observational
inferred← citeshttps://doi.org/10.2139/ssrn.4644577openalex-extracted
Depp1 Emerges as a Prognostic Biomarker Associated with Stroma-Rich and Immunosuppressive Microenvironment and Predicts Poor Chemotherapy Response in Gastric Cancer
inferred← citeshttps://doi.org/10.1001/archsurg.2009.55openalex-snapshot
Trends in Presentation and Survival for Gallbladder Cancer During a Period of More Than 4 Decades—Invited Critique
inferred← citeshttps://doi.org/10.1001/archsurg.2010.3openalex-snapshot
Further Refinement of the Optimal Treatment Following Radical Gastric Resection for Gastric Adenocarcinoma
inferred← citeshttps://doi.org/10.1001/archsurg.2012.983openalex-snapshot
Improving Outcomes After Gastroesophageal Cancer Resection
inferred← citeshttps://doi.org/10.1001/jama.2010.534openalex-snapshot
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jama.2010.553openalex-snapshot
Gastric Cancer—An Enigmatic and Heterogeneous Disease
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2019.21290openalex-snapshot
Evaluation of the Association of Perioperative UGT1A1 Genotype–Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.16240openalex-snapshot
Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.21143openalex-snapshot
Development and Validation of a Computed Tomography–Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.24760openalex-snapshot
Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.35340openalex-snapshot
Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.38432openalex-snapshot
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.0426openalex-snapshot
Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.5557openalex-snapshot
Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.30018openalex-snapshot
Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.49026openalex-snapshot
Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.25581openalex-snapshot
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction
inferred← citeshttps://doi.org/10.1001/jamaoncol.2016.3064openalex-snapshot
Treatment of Gastric and Gastroesophageal Cancers—Do We Really Need Anthracyclines?
inferred← citeshttps://doi.org/10.1001/jamaoncol.2016.6762openalex-snapshot
Mismatch Repair Deficiency, Microsatellite Instability, and Survival
inferred← citeshttps://doi.org/10.1001/jamaoncol.2019.1179openalex-snapshot
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.1065openalex-snapshot
Trends of Clinician Adherence to Evidence-Based Recommendations for Multidisciplinary Oncology Care for Patients With Esophageal Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.2020openalex-snapshot
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers
inferred← citeshttps://doi.org/10.1001/jamaoncol.2020.2701openalex-snapshot
Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases
inferred← citeshttps://doi.org/10.1001/jamaoncol.2021.3603openalex-snapshot
Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma—Is It Based on Evidence or Clinical Wisdom?
inferred← citeshttps://doi.org/10.1001/jamaoncol.2023.4423openalex-snapshot
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma
inferred← citeshttps://doi.org/10.1001/jamasurg.2013.3959openalex-snapshot
Processes of Care in the Multidisciplinary Treatment of Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamasurg.2013.63openalex-snapshot
Predictive Factors of Postoperative Mortality After Junctional and Gastric Adenocarcinoma Resection
inferred← citeshttps://doi.org/10.1001/jamasurg.2015.4068openalex-snapshot
Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation
inferred← citeshttps://doi.org/10.1001/jamasurg.2018.3863openalex-snapshot
Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1001/jamasurg.2019.3473openalex-snapshot
Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamasurg.2022.0182openalex-snapshot
Surgical Management of Gastric Cancer
inferred← citeshttps://doi.org/10.1001/jamasurg.2022.3899openalex-snapshot
Real-time Tracking and Classification of Tumor and Nontumor Tissue in Upper Gastrointestinal Cancers Using Diffuse Reflectance Spectroscopy for Resection Margin Assessment
inferred← citeshttps://doi.org/10.1001/jamasurg.2022.6913openalex-snapshot
Critical Analysis of the Klass-02 Randomized Clinical Trial
inferred← citeshttps://doi.org/10.1001/jamasurg.2026.0085openalex-snapshot
Neoadjuvant Chemotherapy vs Upfront Surgery in Patients With Locally Advanced Colon Cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd001556.pub2openalex-snapshot
Preoperative chemotherapy for resectable thoracic esophageal cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd001556.pub3openalex-snapshot
Preoperative chemotherapy for resectable thoracic esophageal cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd004064.pub3openalex-snapshot
Chemotherapy for advanced gastric cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd004064.pub4openalex-snapshot
Chemotherapy for advanced gastric cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd007905openalex-snapshot
Radiotherapy for gastric cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd007905.pub2openalex-snapshot
Radiotherapy for gastric cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd008107.pub2openalex-snapshot
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
inferred← citeshttps://doi.org/10.1002/14651858.cd008415.pub2openalex-snapshot
Post-surgical chemotherapy versus surgery alone for resectable gastric cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd014748openalex-snapshot
Preoperative chemoradiotherapy versus chemotherapy for adenocarcinoma of the esophagus and esophagogastric junction (AEG): systematic review with individual participant data (IPD) network meta-analysis (NMA)
inferred← citeshttps://doi.org/10.1002/1878-0261.12385openalex-snapshot
Genome‐wide identification of a novel mi RNA ‐based signature to predict recurrence in patients with gastric cancer
inferred← citeshttps://doi.org/10.1002/1878-0261.12728openalex-snapshot
FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
inferred← citeshttps://doi.org/10.1002/9781118468753.ch14openalex-snapshot
Cancer of the oesophagus and stomach
inferred← citeshttps://doi.org/10.1002/9781118468869.ch10openalex-snapshot
Predictive Biomarkers for Therapy in Adenocarcinoma of the Upper Digestive Tract
inferred← citeshttps://doi.org/10.1002/9781118512074.ch40openalex-snapshot
Approach to the Patient with Gas and Bloating
inferred← citeshttps://doi.org/10.1002/9781118512074.ch52openalex-snapshot
Barrett Esophagus and Esophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/9781118512074.ch53openalex-snapshot
Esophageal Squamous Cell Carcinomas and Other Neoplasms
inferred← citeshttps://doi.org/10.1002/9781118555651.ch5openalex-snapshot
Endoscopy in Esophageal Cancer: An Oncologist's Perspective
inferred← citeshttps://doi.org/10.1002/9781118555651.ch9openalex-snapshot
Gastroscopy in Gastric Cancer: An Oncologist's Perspective
inferred← citeshttps://doi.org/10.1002/9781118589199.ch121openalex-snapshot
Radiotherapy for Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1002/9781118655153.ch23openalex-snapshot
Combined modality therapy in locally advanced esophageal cancer
inferred← citeshttps://doi.org/10.1002/9781118781067.ch16openalex-snapshot
EUS of the stomach and duodenum
inferred← citeshttps://doi.org/10.1002/9781118788707.ch12openalex-snapshot
Nutrition in Upper Gastrointestinal Cancer
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm090openalex-snapshot
Neoplasms of the Esophagus
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm090.pub2openalex-snapshot
Neoplasms of the Esophagus
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm091openalex-snapshot
Carcinoma of the Stomach
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm091.pub2openalex-snapshot
Carcinoma of the Stomach
inferred← citeshttps://doi.org/10.1002/9781119599692.ch39openalex-snapshot
Surgical Treatment for Esophageal Cancer
inferred← citeshttps://doi.org/10.1002/9781119600206.ch47openalex-snapshot
Esophageal squamous cell carcinomas and other neoplasms
inferred← citeshttps://doi.org/10.1002/9781119603627.ch14openalex-snapshot
Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1002/9781119697893.ch15openalex-snapshot
EUS of the stomach and duodenum
inferred← citeshttps://doi.org/10.1002/9781119756422.ch4openalex-snapshot
Management of Esophageal Dysplasia and Esophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/9781119809128.ch6openalex-snapshot
Surgical Terminology and Pre‐operative Considerations
inferred← citeshttps://doi.org/10.1002/9781119823766.ch20openalex-snapshot
Early‐Stage Gastroesophageal Cancer and Precursor Lesions
inferred← citeshttps://doi.org/10.1002/9781119876007.ch146openalex-snapshot
Neoadjuvant Treatment of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/9781444303254.ch35openalex-snapshot
Barrett Esophagus and Esophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/9781444306361.ch14openalex-snapshot
Cancer of the Oesophagus and Stomach
inferred← citeshttps://doi.org/10.1002/9781444308099.ch13openalex-snapshot
EUS of the Stomach and Duodenum
inferred← citeshttps://doi.org/10.1002/9781444346220.ch35openalex-snapshot
Surgery for Cancer of the Esophagus and Gastroesophageal Junction
inferred← citeshttps://doi.org/10.1002/advs.202304075openalex-snapshot
EGCG‐LYS Fibrils‐Mediated CircMAP2K2 Silencing Decreases the Proliferation and Metastasis Ability of Gastric Cancer Cells in Vitro and in Vivo
inferred← citeshttps://doi.org/10.1002/advs.76730openalex-snapshot
O‐GlcNAcylation Regulation of SNAP29‐Dependent Autophagy Activation Dictates Chemoresistance in Gastric Cancer
inferred← citeshttps://doi.org/10.1002/agm2.12356openalex-snapshot
The efficacy of neoadjuvant immunotherapy combined with chemotherapy in elderly patients with gastric cancer: A subgroup analysis of the NEOSUMMIT ‐01 study
inferred← citeshttps://doi.org/10.1002/ags3.12069openalex-snapshot
Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: A retrospective single‐institution study
inferred← citeshttps://doi.org/10.1002/ags3.12172openalex-snapshot
Mediastinal lymphadenectomy for esophageal cancer: Differences between two countries, Japan and the Netherlands
inferred← citeshttps://doi.org/10.1002/ags3.12218openalex-snapshot
Re‐emerging role of macroscopic appearance in treatment strategy for gastric cancer
inferred← citeshttps://doi.org/10.1002/ags3.12243openalex-snapshot
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer
inferred← citeshttps://doi.org/10.1002/ags3.12301openalex-snapshot
Controversies in preoperative therapy in esophageal cancer: Current evidence and ongoing research
inferred← citeshttps://doi.org/10.1002/ags3.12350openalex-snapshot
Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
inferred← citeshttps://doi.org/10.1002/ags3.12352openalex-snapshot
Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer
inferred← citeshttps://doi.org/10.1002/ags3.12388openalex-snapshot
Long‐term results of a randomized controlled trial comparing neoadjuvant Adriamycin, cisplatin, and 5‐fluorouracil vs docetaxel, cisplatin, and 5‐fluorouracil followed by surgery for esophageal cancer (OGSG1003)
inferred← citeshttps://doi.org/10.1002/ags3.12438openalex-snapshot
Essential updates 2019/2020: Perioperative and surgical management of gastric cancer
inferred← citeshttps://doi.org/10.1002/ags3.12439openalex-snapshot
History and emerging trends in chemotherapy for gastric cancer
inferred← citeshttps://doi.org/10.1002/ags3.12444openalex-snapshot
Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature
inferred← citeshttps://doi.org/10.1002/ags3.12565openalex-snapshot
Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery
inferred← citeshttps://doi.org/10.1002/ags3.12691openalex-snapshot
Current progress in perioperative chemotherapy for biliary tract cancer
inferred← citeshttps://doi.org/10.1002/ags3.12706openalex-snapshot
Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer
inferred← citeshttps://doi.org/10.1002/ags3.12717openalex-snapshot
Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery
inferred← citeshttps://doi.org/10.1002/ags3.12840openalex-snapshot
Feasibility and predictive factors on the completion of docetaxel plus S‐1 adjuvant chemotherapy in pathological stage III gastric cancer
inferred← citeshttps://doi.org/10.1002/ags3.70041openalex-snapshot
Essential Updates 2023/2024: Recent Advances of Multimodal Approach in Patients for Gastric Cancer
inferred← citeshttps://doi.org/10.1002/ags3.70247openalex-snapshot
Multidisciplinary Treatment for Esophagogastric Junction Cancer From a Dutch Perspective
inferred← citeshttps://doi.org/10.1002/agt2.13openalex-snapshot
Self‐assembling bile pigments for cancer diagnosis and therapy
inferred← citeshttps://doi.org/10.1002/bjs.10149openalex-snapshot
Role of omentectomy as part of radical surgery for gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.10226openalex-snapshot
Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy
inferred← citeshttps://doi.org/10.1002/bjs.10304openalex-snapshot
Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry
inferred← citeshttps://doi.org/10.1002/bjs.10435openalex-snapshot
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer
inferred← citeshttps://doi.org/10.1002/bjs.10509openalex-snapshot
Prognostic factors for survival in patients with pT1 N+ or T2–3 N0 gastric cancer in Japan
inferred← citeshttps://doi.org/10.1002/bjs.10550openalex-snapshot
Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer
inferred← citeshttps://doi.org/10.1002/bjs.10627openalex-snapshot
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
inferred← citeshttps://doi.org/10.1002/bjs.10712openalex-snapshot
[18F]Fluorodeoxyglucose PET/CT and prediction of histopathological response to neoadjuvant chemotherapy for adenocarcinoma of the oesophagus and oesophagogastric junction
inferred← citeshttps://doi.org/10.1002/bjs.10729openalex-snapshot
Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery
inferred← citeshttps://doi.org/10.1002/bjs.10745openalex-snapshot
Health-related quality of life after open transhiatal and transthoracic oesophagectomy for cancer
inferred← citeshttps://doi.org/10.1002/bjs.10802openalex-snapshot
Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.10836openalex-snapshot
Morbidity and mortality according to age following gastrectomy for gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.10900openalex-snapshot
Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/bjs.10931openalex-snapshot
Overall survival before and after centralization of gastric cancer surgery in the Netherlands
inferred← citeshttps://doi.org/10.1002/bjs.10960openalex-snapshot
Oesophagectomy with or without supraclavicular lymphadenectomy after neoadjuvant treatment for squamous cell carcinoma of the oesophagus
inferred← citeshttps://doi.org/10.1002/bjs.11118openalex-snapshot
Changes in gut hormones, glycaemic response and symptoms after oesophagectomy
inferred← citeshttps://doi.org/10.1002/bjs.11181openalex-snapshot
Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy
inferred← citeshttps://doi.org/10.1002/bjs.11184openalex-snapshot
Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction
inferred← citeshttps://doi.org/10.1002/bjs.11218openalex-snapshot
Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer
inferred← citeshttps://doi.org/10.1002/bjs.11461openalex-snapshot
Machine learning to predict early recurrence after oesophageal cancer surgery
inferred← citeshttps://doi.org/10.1002/bjs.11476openalex-snapshot
Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
inferred← citeshttps://doi.org/10.1002/bjs.11864openalex-snapshot
Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin.
inferred← citeshttps://doi.org/10.1002/bjs.5729openalex-snapshot
Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.5785openalex-snapshot
Tailoring treatments for curable gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.6021openalex-snapshot
Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection
inferred← citeshttps://doi.org/10.1002/bjs.6156openalex-snapshot
Caveats in the interpretation of the surgical literature
inferred← citeshttps://doi.org/10.1002/bjs.6370openalex-snapshot
Gastric cancer in Europe (Br J Surg 2008; 95: 406–408)
inferred← citeshttps://doi.org/10.1002/bjs.6408openalex-snapshot
Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.6665openalex-snapshot
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.6780openalex-snapshot
High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.7231openalex-snapshot
Review of open and minimal access approaches to oesophagectomy for cancer
inferred← citeshttps://doi.org/10.1002/bjs.7528openalex-snapshot
Changing clinical and pathological features of gastric cancer over time
inferred← citeshttps://doi.org/10.1002/bjs.7586openalex-snapshot
Systematic review of intraperitoneal chemotherapy for gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.7758openalex-snapshot
Role of positron emission tomography–computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/bjs.7812openalex-snapshot
Prognostic significance of peritoneal washing cytology in patients with gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.8787openalex-snapshot
Influence of hospital type on outcomes after oesophageal and gastric cancer surgery
inferred← citeshttps://doi.org/10.1002/bjs.8884openalex-snapshot
Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction
inferred← citeshttps://doi.org/10.1002/bjs.8973openalex-snapshot
Impact of postoperative morbidity on long-term survival after oesophagectomy
inferred← citeshttps://doi.org/10.1002/bjs.8987openalex-snapshot
Impact of targeted neoadjuvant therapies in the treatment of solid organ tumours
inferred← citeshttps://doi.org/10.1002/bjs.9004openalex-snapshot
Improving outcomes in gastrointestinal cancer
inferred← citeshttps://doi.org/10.1002/bjs.9418openalex-snapshot
Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers
inferred← citeshttps://doi.org/10.1002/bjs.9456openalex-snapshot
Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer
inferred← citeshttps://doi.org/10.1002/bjs.9484openalex-snapshot
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
inferred← citeshttps://doi.org/10.1002/bjs.9632openalex-snapshot
Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs.9650openalex-snapshot
Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery
inferred← citeshttps://doi.org/10.1002/bjs.9792openalex-snapshot
Determinants of improved survival after oesophagectomy for cancer
inferred← citeshttps://doi.org/10.1002/bjs.9891openalex-snapshot
Quality control of lymph node dissection in the Dutch Gastric Cancer Trial
inferred← citeshttps://doi.org/10.1002/bjs5.30openalex-snapshot
Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy
inferred← citeshttps://doi.org/10.1002/bjs5.50110openalex-snapshot
Safety and feasibility of preoperative exercise training during neoadjuvant treatment before surgery for adenocarcinoma of the gastro-oesophageal junction
inferred← citeshttps://doi.org/10.1002/bjs5.50211openalex-snapshot
Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus
inferred← citeshttps://doi.org/10.1002/bjs5.50219openalex-snapshot
Trainee performance in radical gastrectomy and its effect on outcomes
inferred← citeshttps://doi.org/10.1002/bjs5.50230openalex-snapshot
Value of individual surgeon performance metrics as quality assurance measures in oesophagogastric cancer surgery
inferred← citeshttps://doi.org/10.1002/bjs5.50270openalex-snapshot
Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery
inferred← citeshttps://doi.org/10.1002/bjs5.50337openalex-snapshot
Effects of high-intensity exercise training on physical fitness, quality of life and treatment outcomes after oesophagectomy for cancer of the gastro-oesophageal junction: PRESET pilot study
inferred← citeshttps://doi.org/10.1002/bjs5.50338openalex-snapshot
Perirenal fat thickness as a predictor of postoperative complications after laparoscopic distal gastrectomy for gastric cancer
inferred← citeshttps://doi.org/10.1002/bjs5.65openalex-snapshot
Impact of incremental circumferential resection margin distance on overall survival and recurrence in oesophageal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cac2.12193openalex-snapshot
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
inferred← citeshttps://doi.org/10.1002/cac2.12318openalex-snapshot
Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates
inferred← citeshttps://doi.org/10.1002/cac2.12516openalex-snapshot
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
inferred← citeshttps://doi.org/10.1002/cac2.12645openalex-snapshot
Current status and perspectives of esophageal cancer: a comprehensive review
inferred← citeshttps://doi.org/10.1002/cam4.1144openalex-snapshot
Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer
inferred← citeshttps://doi.org/10.1002/cam4.1274openalex-snapshot
Medical management of gastric cancer: a 2017 update
inferred← citeshttps://doi.org/10.1002/cam4.2204openalex-snapshot
Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central‐Eastern European study
inferred← citeshttps://doi.org/10.1002/cam4.2948openalex-snapshot
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.3224openalex-snapshot
The efficacy and safety of neoadjuvant chemotherapy on patients with advanced gastric cancer: A multicenter randomized clinical trial
inferred← citeshttps://doi.org/10.1002/cam4.3350openalex-snapshot
Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer
inferred← citeshttps://doi.org/10.1002/cam4.3651openalex-snapshot
Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities
inferred← citeshttps://doi.org/10.1002/cam4.3724openalex-snapshot
The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
inferred← citeshttps://doi.org/10.1002/cam4.470openalex-snapshot
Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10‐year follow‐up confirms prognostic significance
inferred← citeshttps://doi.org/10.1002/cam4.4980openalex-snapshot
Partial omentectomy maybe practicable for T3 or shallower gastric cancer patients
inferred← citeshttps://doi.org/10.1002/cam4.5414openalex-snapshot
Perioperative treatment and biomarker analysis of LP002 , an anti‐PD‐L1 antibody, plus chemotherapy in resectable gastric and gastroesophageal junction cancer
inferred← citeshttps://doi.org/10.1002/cam4.5977openalex-snapshot
Analysis of the efficacy and influencing factors of preoperative P‐SOX neoadjuvant chemotherapy regimen for progressive gastric cancer—construction of a clinical prediction model
inferred← citeshttps://doi.org/10.1002/cam4.6263openalex-snapshot
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction ( GEJ ), and stomach adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6320openalex-snapshot
The impact of preoperative waiting time in Stage II – III gastric or gastroesophageal junction cancer: A population‐based cohort study
inferred← citeshttps://doi.org/10.1002/cam4.6597openalex-snapshot
Tumor regression grade combined with post‐therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.7006openalex-snapshot
Efficacy and safety of camrelizumab combined with oxaliplatin and S‐1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II , single‐arm study
inferred← citeshttps://doi.org/10.1002/cam4.7076openalex-snapshot
Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/cam4.71079openalex-snapshot
Efficacy and Safety of a 3‐Weekly TS ‐1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study
inferred← citeshttps://doi.org/10.1002/cam4.7122openalex-snapshot
Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: Data from a phase III clinical trial
inferred← citeshttps://doi.org/10.1002/cam4.71619openalex-snapshot
Comparative Effectiveness and Modality‐Dependent Prognostic Value of Pathological Response Following Neoadjuvant Therapy for Locally Advanced Gastric Cancer
inferred← citeshttps://doi.org/10.1002/cam4.71753openalex-snapshot
Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives
inferred← citeshttps://doi.org/10.1002/cam4.720openalex-snapshot
Organotypic slice cultures of human gastric and esophagogastric junction cancer
inferred← citeshttps://doi.org/10.1002/cam4.72132openalex-snapshot
Fluorescent Multiplex Immunohistochemistry ( mIHC ) Analyses of Local Advanced Gastric Cancer Patients After Neoadjuvant Chemotherapy Revealed the Status of Tumor‐Infiltrating Immune Cells and Predicted the Clinical Outcome
inferred← citeshttps://doi.org/10.1002/cam4.885openalex-snapshot
Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.989openalex-snapshot
Validation of micro RNA pathway polymorphisms in esophageal adenocarcinoma survival
inferred← citeshttps://doi.org/10.1002/cbf.3537openalex-snapshot
Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress
inferred← citeshttps://doi.org/10.1002/ccr3.6982openalex-snapshot
Role of shrinkage in esophageal–gastric junction cancer
inferred← citeshttps://doi.org/10.1002/cjp2.137openalex-snapshot
Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein–Barr virus infection and high‐ and low‐microsatellite instability
showing the first 200 of 6169 · page through all 6169
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.